Whats new

Whats new.

Ladenburg Thalmann - Next Is Dose Optimization for BC Program; Reiterate Buy, $8.30 PT (Analyst: Ahu Demir, PhD)

March 6th 2024

For a copy of this research report please contact your Ladenburg Thalmann advisor

Go back